All potential acute ischemic stroke patients meeting criteria for the use of IV tPA should be offered treatment. The facts are clear, and all that remains is further provider and patient education.

IV tPA remains the standard of care of acute ischemic stroke patients presenting within established time windows without contraindications, and hospitals should continue to concentrate on system ...

During an ischemic stroke, blood vessels in the brain are blocked or narrowed. During a hemorrhagic stroke, there's bleeding ...

Actor Mithun Chakraborty was recently diagnosed with Ischemic Cerebrovascular ... to the patient within a short window. Tissue plasminogen activator (TPA) or mechanical thrombectomy (a type ...

Intravenous delivered tPA is approved by the FDA for the treatment of acute ischemic stroke. The drug can make a big difference, but only if it is given within a specified time frame (up to four and a ...

The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

The severity of left ventricular diastolic dysfunction affects risk for incident stroke and transient ischemic attack, as well as major bleeding.

In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.

Portable point-of-care blood tests, done by EMS before hospital arrival, need validation but could guide treatment and ...

During an ischemic stroke, the blood supply to a region ... and other kinds of tissue plasminogen activator drugs. This treatment is effective if the stroke is quickly diagnosed and evaluated ...

Market Trend: A notable trend in the acute ischemic stroke therapeutics market is the advancement of reperfusion therapies. The use of tissue plasminogen activator (tPA) has been a standard ...

My neighbor had a stroke and received a "clot buster" medication. Then, I found out my uncle had a surgery after a stroke.